Novotech Featured Reports

  1. Europe At A Crossroads: Biotech Investment, Regulation, And Partnership In Real Life 12/10/2025

    Position your biotech for Europe’s next phase by aligning strong science, smart clinical strategy, and the right global partners to navigate funding, regulation, and growth.

  2. ESMO Congress 2025: Highlights From Berlin 11/24/2025

    Turn the insights from this year’s ESMO into action by partnering to accelerate innovation through smarter trial design, stronger biomarker planning, and truly global collaboration.

  3. The Shift Toward Flexible FSP Models 11/13/2025

    Flexible FSP models are reshaping clinical outsourcing by offering sponsors scalable, cost-predictable partnerships that preserve control, enhance quality, and support long-term strategic goals.

  4. How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology? 11/7/2025

    By directing radioactive isotopes straight to diseased tissue, these agents deliver potent, localized treatment while sparing healthy cells — a major leap forward for patients with metastatic or treatment-resistant cancers.

  5. Highlights From The 2025 International Hepatitis B Meeting 11/7/2025

    For biotech and pharmaceutical teams, the core message was clear: progress is accelerating, but success still depends on smart study design, fit-for-purpose endpoints, and operational execution.

  6. How CROs, Sites, PIs, And Sponsors Work Better Together 11/7/2025

    Each role is critical, yet operating in isolation results in slower timelines, duplicated effort, and missed opportunities. When collaboration replaces coordination, trials gain speed, quality, and patient trust.

  7. Using AI Tools In Hepatology Drug Development 10/27/2025

    Explore how AI can help overcome key challenges in hepatology trials — from site selection and patient matching to data integration and engagement — while ensuring diversity, privacy, and transparency.

  8. The Evolving RNA Landscape: Navigating Science, Strategy, And Global Markets 10/27/2025

    Learn how to streamline development, reduce costs, and accelerate the path to market for next-generation RNA therapies.

  9. Navigating The Planning And Execution Of Multiregional Trials 8/27/2025

    Plan your first overseas study or expand an established pipeline; with the help of strategic insights to navigate complexities, maximize investment, and position new therapies for international success.

  10. Why New Zealand Is Emerging As A Clinical Trial Hub 8/27/2025

    New Zealand is rapidly emerging as a premier destination for clinical research, offering a unique combination of regulatory agility, scientific expertise, and cost efficiency.